Shopping Cart
- Remove All
Your shopping cart is currently empty
'3'-Hydroxy Repaglinide, a primary CYP2C8 metabolite of Repaglinide, is derived from carbamoylmethyl benzoic acid and is used in the treatment of type II diabetes.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,895 | 10-14 weeks | |
| 50 mg | $3,030 | 10-14 weeks | |
| 100 mg | Inquiry | 10-14 weeks |
| Description | '3'-Hydroxy Repaglinide, a primary CYP2C8 metabolite of Repaglinide, is derived from carbamoylmethyl benzoic acid and is used in the treatment of type II diabetes. |
| Molecular Weight | 468.59 |
| Formula | C27H36N2O5 |
| Cas No. | 874908-14-2 |
| Relative Density. | 1.186g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.